Anlon Healthcare
add_icon

Anlon Healthcare

15.08
+0.21
(1.41%)
Market Cap
801.52 Cr
PE Ratio
27.09
Volume
20,71,289.00
Day High - Low
15.16 - 14.78
52W High-Low
172.75 - 9.08
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
801.52 Cr
EPS
5.93
PE Ratio
27.09
PB Ratio
3.44
Book Value
4.33
EBITDA
46.14
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
25.51
Debt to Equity
1.46
Forecast For
Actual

Company News

View All News
Caret
positive
Anlon Healthcare Ltd incorporated Anlon Medicare Private Limited on July 09, 2026, to manufacture surgical implants and medical devices. The subsidiary holds an authorized capital of Rs. 5,000,000.
neutral
Anlon Healthcare CMD Punitkumar Rasadia discussed business performance and growth strategy on Money TV. No unpublished price sensitive information was shared during the interaction.
positive
Anlon Healthcare Ltd approved incorporating Anlon Medicare and Anlon Biologics on July 1, 2026, investing ₹17.5 lakh to expand into surgical implants and biologics.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,954.00
#1 4,68,830.05
40.50
#1 61,673.90
12.69
#1 11,565
25.80
63.70
7,305.00
1,93,924.80
76.36
11,067.00
13.95
2,568
13.44
67.54
5,065.20
1,92,663.93
89.58
13,886.20
20.34
2,138
-26.91
67.43
1,393.00
1,12,532.85
29.60
29,044.60
2.24
3,870
-55.32
41.15
1,113.80
1,12,074.34
22.00
27,657.90
17.64
5,026
7.82
47.79
2,396.30
1,09,566.63
#1 20.54
29,038.90
#1 26.75
5,356
#1 87.72
46.58
2,557.40
1,05,619.59
54.21
14,636.40
14.85
1,938
31.75
57.20
1,166.30
97,347.45
31.02
35,058.60
3.90
4,158
-69.10
27.38
1,523.40
87,653.07
25.42
33,384.70
3.21
3,376
1.99
47.69
1,568.30
84,665.71
95.73
6,867.80
22.01
890
21.18
62.10
Growth Rate
Revenue Growth
46.47 %
Net Income Growth
42.83 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
-2.90 %

Quarterly Financial Results

Quarterly Financials
Mar 2025
Dec 2025
Mar 2026
Revenue
49
36
51
Expenses
32
23
36
EBITDA
17
13
15
Operating Profit %
35 %
35 %
30 %
Depreciation
1
0
0
Interest
1
2
1
Profit Before Tax
16
11
14
Tax
-1
6
3
Net Profit
17
5
11
EPS in ₹
5.15
1.13
2.33

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
71
85
112
128
181
317
Fixed Assets
29
27
26
27
23
40
Current Assets
40
58
86
101
159
260
Capital Work in Progress
0
0
0
0
0
0
Investments
0
2
4
1
1
76
Other Assets
43
56
82
100
158
0
Total Equity & Liabilities
71
85
112
128
181
317
Current Liabilities
31
29
44
50
60
101
Non Current Liabilities
38
55
61
57
41
7
Total Equity
2
2
7
21
80
210
Reserve & Surplus
-10
-10
-5
5
41
157
Share Capital
12
12
12
16
40
53

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
-1
2
-1
Investing Activities
-3
-0
-0
-3
3
Operating Activities
-15
-2
-3
-3
-23
Financing Activities
16
3
2
8
19

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
52.68 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
0.00 %
0.23 %
0.32 %
1.67 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
2.83 %
4.49 %
4.60 %
1.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
20.73 %
23.58 %
24.38 %
26.19 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
23.75 %
19.02 %
18.02 %
18.24 %
No of Share Holders
109
131
9,125
135
9,126
11,412
12,484
34,671

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 13.91 142.50
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2026 12.01 12.53
24 Apr 2026 BONUS Bonus
1:1
24 Apr 2026 12.19 14.38
06 Mar 2026 SPLIT Split
2:10
24 Apr 2026 11.19 11.19
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 13.89 14.23

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Announcement For Incorporation Of Subsidiary CompanyJul 11, 2026
Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare LimitedJul 09, 2026
Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra Former Senior Anchor @CnbcawaazJul 06, 2026
Disclosure Regarding Interview Of Chairman & Managing Director With Money TVJul 01, 2026
Board Meeting Outcome for Incorporation Of Subsidiaries Of Anlon Healthcare LimitedJul 01, 2026
Closure of Trading WindowJun 30, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit.Jun 11, 2026
Intimation Regarding Media Interaction Of Chairman & Managing DirectorJun 09, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJun 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026May 29, 2026
Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026May 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon.May 23, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
Updates On AcquisitionMay 08, 2026
Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 27, 2026
Announcement under Regulation 30 (LODR)-AllotmentApr 27, 2026
Intimation Of New ISINApr 22, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 16, 2026
Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private LimitedApr 16, 2026
Announcement under Regulation 30 (LODR)-Credit RatingApr 15, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationApr 09, 2026
Corporate Action-Board recommends Bonus IssueApr 09, 2026
Corporate Action-updates on Outcome of Sub division / Stock SplitApr 09, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 08, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 11, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 09, 2026
Corporate Action-Board to consider Bonus IssueMar 06, 2026
Corporate Action-Intimation of Sub division / Stock SplitMar 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Of Anlon Healthcare Limited Held On Friday March 06 2026Mar 06, 2026
Closure of Trading WindowMar 02, 2026
Board Meeting Intimation for Stock Split And Issue Of Bonus SharesMar 02, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 27, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 19, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026

Technical Indicators

RSI(14)
Neutral
45.15
ATR(14)
Volatile
0.62
STOCH(9,6)
Neutral
27.23
STOCH RSI(14)
Neutral
32.04
MACD(12,26)
Bearish
-0.12
ADX(14)
Weak Trend
24.41
UO(9)
Bearish
37.67
ROC(12)
Downtrend And Accelerating
-2.94
WillR(14)
Oversold
-84.05